体内
生物物理学
内吞作用
离体
体内分布
纳米技术
纳米颗粒
化学
胶体金
纳米毒理学
材料科学
细胞
生物化学
生物
生物技术
作者
Xiaona Wen,Luping Ou,Gabriel Cutshaw,Saji Uthaman,Yu‐Chuan Ou,Tian Zhu,Sarah Szakas,Brandon Carney,Jacob L. Houghton,Alexander Gundlach‐Graham,Marjan Rafat,Kai Yang,Rizia Bardhan
出处
期刊:Small
[Wiley]
日期:2023-03-25
卷期号:19 (29)
被引量:3
标识
DOI:10.1002/smll.202204293
摘要
Abstract The in vivo dynamics of nanoparticles requires a mechanistic understanding of multiple factors. Here, for the first time, the surprising breakdown of functionalized gold nanostars (F‐AuNSs) conjugated with antibodies and 64 Cu radiolabels in vivo and in artificial lysosomal fluid ex vivo, is shown. The short‐term biodistribution of F‐AuNSs is driven by the route of systemic delivery (intravenous vs intraperitoneal) and long‐term fate is controlled by the tissue type in vivo. In vitro studies including endocytosis pathways, intracellular trafficking, and opsonization, are combined with in vivo studies integrating a milieu of spectroscopy and microcopy techniques that show F‐AuNSs dynamics is driven by their physicochemical properties and route of delivery. F‐AuNSs break down into sub‐20 nm broken nanoparticles as early as 7 days postinjection. Martini coarse‐grained simulations are performed to support the in vivo findings. Simulations suggest that shape, size, and charge of the broken nanoparticles, and composition of the lipid membrane depicting various tissues govern the interaction of the nanoparticles with the membrane, and the rate of translocation across the membrane to ultimately enable tissue clearance. The fundamental study addresses critical gaps in the knowledge regarding the fate of nanoparticles in vivo that remain a bottleneck in their clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI